MktsMarkets

Jaguar Health, Inc.
NASDAQ: JAGXKey statistics
JAGX News
Stories mentioning JAGX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 20,272 | 3,235 | 3,083 | 2,979 | 2,214 | 3,509 | 3,108 | 2,721 |
| Cost of Goods Sold | 1,158 | 2,200 | 532.00 | 527.00 | 515.00 | 557.00 | 541.00 | 427.00 |
| Gross Profit | 19,114 | 1,035 | 2,551 | 2,452 | 1,699 | 2,952 | 2,567 | 2,294 |
| Operating Expenses | ||||||||
| Research & Development | 3,928 | 14,313 | 3,658 | 3,265 | 3,730 | 4,534 | 4,043 | 3,653 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 10,182 | (21,242) | (7,238) | (8,007) | (9,421) | (8,157) | (7,262) | (7,197) |
| Interest Income | ||||||||
| Interest Expense | 699.00 | 132.00 | 6.00 | (15.00) | (56.00) | (110.00) | (162.00) | (108.00) |
| Other Expense | 205.00 | (297.00) | (94.00) | 322.00 | 112.00 | 378.00 | 168.00 | (729.00) |
| Pretax Income | 8,723 | (23,193) | (9,648) | (10,560) | (10,596) | (10,234) | (10,021) | (9,628) |
| Tax Provision | 0.00 | 0.00 | 0.00 | |||||
| Net Income (Loss) | (23,202) | (9,502) | (10,407) | (10,464) | (9,920) | (9,854) | (9,492) | |
| Earnings Per Share (Basic) | (13.60) | (9.95) | (6.28) | (10.26) | (584.45) | (33.63) | (26.29) | (2.66) |
| Earnings Per Share (Diluted) | (13.60) | (9.95) | (6.28) | (10.26) | (584.45) | (33.63) | (26.29) | (2.66) |
| Weighted Average Shares Outstanding (Basic) | 516.00 | 2,332 | 1,513 | 1,015 | 18.00 | 295.00 | 375.00 | 3,573 |
| Weighted Average Shares Outstanding (Diluted) | 516.00 | 2,332 | 1,513 | 1,015 | 18.00 | 295.00 | 375.00 | 3,573 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About JAGX
Jaguar Health, Inc. (NASDAQ: JAGX) is a stock listed on the Nasdaq Stock Market under the ticker symbol JAGX. It last traded at $2.98 (Oct 19, 2026, 2:37 PM ET), down 15.5% on the day. That gives Jaguar Health a market capitalisation of $6.9M.
Over the past 52 weeks JAGX has traded between $2.35 and $1,207.50.
Revenue for the quarter ended Mar 31, 2026 was $20.3M. Revenue was up 816% from $2.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $20.3M | — | — |
| Dec 31, 2025 | $3.2M | -$23.2M | -717.2% |
| Sep 30, 2025 | $3.1M | -$9.5M | -308.2% |
| Jun 30, 2025 | $3.0M | -$10.4M | -349.3% |
From Jaguar Health’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…